Download PDF
Erfahrungsheilkunde 2017; 66(05): 268-276
DOI: 10.1055/s-0043-119018
Wissen
MVS Medizinverlage Stuttgart GmbH & Co. KG Stuttgart · New York

Curcuma longa in der Onkologie

Vera Maria Kneer
Further Information

Publication History

Publication Date:
19 October 2017 (online)

    Permissions and Reprints

Zusammenfassung

Curcuma longa wird seit Jahrtausenden in der ayurvedischen und chinesischen Medizin bei zahlreichen Erkrankungen eingesetzt. Im Mittelpunkt der Forschung steht überwiegend Curcumin, ein wesentlicher Bestandteil des Extrakts. In-vitro- und In-vivo-Studien haben vielfältige Wirkmechanismen u. a. antioxidative und antiinflammatorische Wirkungen aufgezeigt. Bei zahlreichen Erkrankungen, v. a. mit entzündlicher Genese sowie bei Tumorerkrankungen, hat sich der Einsatz von Curcumin als effektiv erwiesen. Curcumin beeinflusst alle Signalwege von der Karzinogenese bis zur Metastasierung. Formulierungen mit verbesserter Bioverfügbarkeit sowie neue Applikationsformen versuchen pharmakologische Schwächen des Pflanzenstoffes auszugleichen. Aktuell werden in Patientenstudien z. B. Kombinationen mit Chemotherapien und Strahlentherapien erprobt. Daneben sind aber auch Kombinationen von Curcuma mit anderen Pflanzenstoffen zur Optimierung therapeutischer Effekte in der integrativen Onkologie von großem Interesse.

Abstract

Curcuma longa has been used for thousands of years in Ayurvedic and Chinese medicine for various diseases. The focus of research is predominantly on curcumin, an essential component of the extract. In vitro as well as in vivo studies have shown various mechanisms of action such as antioxidant, anti-inflammatory effects. The use of curcumin has proven to be effective in numerous diseases, including inflammatory genesis and tumor diseases. Curcumin affects all signaling pathways from carcinogenesis to metastasis. Formulations with improved bioavailability as well as new forms of application attempt to balance pharmacological weaknesses of the plant material. Currently, combinations of chemotherapies and radiation therapies are tested in patient studies. In addition, combinations of curcuma longa with other plants are also of great interest for the optimization of therapeutic effects in integrative oncology.

Schlüsselwörter

Curcuma - Kurkuma - Curcumin - Kurkumin - Bioverfügbarkeit - Onkologie - klinische Studie

Key words

Curcumin - inflammation - bioavailability - application - clinical trial
 

  • Literatur

  • 1 Bimonte S, Barbieri A, Leongito M. et al. Curcumin AntiCancer Studies in Pancreatic Cancer. Nutrients 2016; Jul 8 (07) 433
    CrossrefPubMedGoogle Scholar
  • 2 Bose S, Panda AK, Mukherjee S. et al. Curcumin and tumor immune-editing: resurrecting the immune system. Cell division 2015; 10: 6
    CrossrefPubMedGoogle Scholar
  • 3 Byeong MK, Yunkyung H, Seunghoon L. et al. Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy. Int J Mol Sci 2015; Nov 16 (11) 26880-26913
    CrossrefPubMedGoogle Scholar
  • 4 Dae-Woon E, Ji Hwan L, Young-Joo K. et al. Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells,. BMB Rep 2015; 48 (08) 461-466
    CrossrefPubMedGoogle Scholar
  • 5 Das Mandal S, Mandal S, Patel J. Brain targeting efficiency of Curcumin loaded mucoadhesive microemulsion through intranasal route. Journal of Pharmaceutical Investigation April 2016; 46 (02) 179-188
    CrossrefPubMedGoogle Scholar
  • 6 Demiray M, Sahinbas H, Atahan S. et al. Successful treatment of c-kit positive metastatic Adenoid Cystic Carcinoma (ACC) with a combination of curcumin plus Imatinib. A case report. Complement Thera. Med 2016; Aug 27: 108-113
    PubMedGoogle Scholar
  • 7 Di Martino RMC, Bisi A, Rampa A. et al. Recent progress on curcumin-based therapeutics: a patent review (2012–2016). Part I: Curcumin. Expert opin Ther Pat 2017; May 27 (05) 579-590
    CrossrefPubMedGoogle Scholar
  • 8 Elad S, Meidan I, Sellam G. et al. Topical curcumin for the prevention of oral mucositis in pediatric patient: case series. Altern Ther Health Med. 2013; May–Jun 19 (03) 21-24
    PubMedGoogle Scholar
  • 9 Fadus MC, Lau C, Bikchandani J. et al. Curcumin: An age-old anti-inflammatory and anti-neoplastic agent. J Tradit Complement Med 2017; Jul 7 (03) 339-346
    CrossrefPubMedGoogle Scholar
  • 10 Fantini M, Benvenuto M, Musuelli L. et al. In vitro and in vivo antitumoral effects of combinations of Polyphenols and Anticancer drugs. Inf. J. Mol Sci 2015; 16 (05) 9246-9282
    PubMedGoogle Scholar
  • 11 Gupta SC, Parchva SW, Koh W. et al. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol 2012; Mar 39 (03) 283-99
    CrossrefPubMedGoogle Scholar
  • 12 Helson L. Curcumin (diferuloylmethane) delivery methods: a review, Biofactors. 2013; Jan–Feb 39 (01) 21-26
    PubMedGoogle Scholar
  • 13 Hong M, Tan HY, Li S. et al. Cancer Stem Cells: The Potential Targets of Chinese Medicines and Their Active Compounds. Int J Mol Sci 2016; Jun 17 (06) 893
    CrossrefPubMedGoogle Scholar
  • 14 www.ardmediathek.de/tv/alles-wissen/Kurkuma-in-der-Forschung/hr-fernsehen/Video?bcastId=3416170&documentId=42219806
    PubMed
  • 15 www.clinicaltrials.gov/ct2/results?cond=cancer&term=Curcumin&cntry1=&state1=&recrs= Stand: 10.09.2017
    PubMed
  • 16 www.smartpatients.com/trials/ NCT 02439385; Stand: 10.09.2017
    PubMed
  • 17 www.ernaehrungsumschau.de/fileadmin/ErnaehrungsUmschau/pdfs/pdf_2015/11_15/EU11_2015_Special_Kocher_Eng.pdf
    PubMed
  • 18 www.turmericforhealth.com/general-info/turmeric-curcumin-dosage-for-cancer-a-scientific-plan Stand: 10.09.2017
    PubMed
  • 19 Hu X-Q, Sun Y, Lau E. et al. Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer. Current Cancer Drug Targets 2016; 16: 346-356
    CrossrefPubMedGoogle Scholar
  • 20 Huang H, Xuan C, Dongli L. et al. Combination of α-Tomatine and Curcumin Inhibits Growth and Induces Apoptosis in Human Prostate Cancer Cells. Plos. 2015 Dec 2. 10. (12)
    PubMedGoogle Scholar
  • 21 Kim H, Gupta SC, Park B. et al. Turmeric (Curcuma longa) inhibits inflammatory nuclear factor (NF)-κB and NF-κB-regulated gene products and induces death receptors leading to suppressed proliferation, induced chemosensitization, and suppressed osteoclastogenesis. Mol nutr Food Res 2012; 56 (03) 454-465
    CrossrefPubMedGoogle Scholar
  • 22 Kim W, Kang J, Youn B.. et al. Effects of traditional oriental medicines as anti-cytotoxic agents in radiotherapy. Oncology Letters. April 18 2017
    PubMedGoogle Scholar
  • 23 Klinger NV, Sandeep M. Therapeutic Potential of Curcumin for the Treatment of Brain Tumors, Oxidative Medicine and Cellular Longevity. 2016 9324085
    PubMedGoogle Scholar
  • 24 Kunnumakkara AB, Bordoloi D, Padmavathi G. et al. Curcumin, the golden nutraceutical multitargeting for multiple chronic diseases. BR J Pharmacol 2017; Jun 174 (11) 1325-1348
    CrossrefPubMedGoogle Scholar
  • 25 Mahammedi H, Planchat E, Pouget M. et al. The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study. Oncology 2016; 90 (02) 69-78
    CrossrefPubMedGoogle Scholar
  • 26 McCubrey J, Lertpiriyapong K, Steelman LS. et al. Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs. Aging (Albany NY) 2017; Jun 9 (06) 1477-1536
    PubMedGoogle Scholar
  • 27 Mollaei H, Babei E. Therapeutic Potential of Novel Nano-Based Compounds in Vitro and in Vivo,. Asian Pac J Cancer Prev 2017; Apr 1 18 (04) 885-888
    PubMedGoogle Scholar
  • 28 Montgomery A, Adeyeni T, San Ket. et al. Curcumin sensitizes Silymarin to exert synergistic anticancer activity in Colon cancer cells. J Cancer 2016; 7 (10) 1250-1257
    CrossrefPubMedGoogle Scholar
  • 29 Niedzwiecki A, Roomi MW, Kalinovsky T. et al. Review Anticancer efficacy of Polyphenols and their combinations. Nutrients Sept. 2016 9. 8(9)
    PubMedGoogle Scholar
  • 30 Panda AK, Chakraborty D, Sarkar I. et al. New insights into therapeutic activity and anticancer properties of curcumin. J Exp Pharmacol 2017; 9: 31-45
    PubMedGoogle Scholar
  • 31 Prasad NR, Muthusamy G, Shanmugam M. et al. South Asian Medicinal compounds as Modulators of Resistance to Chemotherapy and Radiotherapy. Cancers 2016; 8 (03) 32
    CrossrefPubMedGoogle Scholar
  • 32 Quadir M. et. al. Mini Review. Curcumin: a Polyphenol with Molecular Targets for Cancer Control. Asian Pacific Journal of Cancer Prevention 2016; 17 (06) 2735-2749
    PubMedGoogle Scholar
  • 33 Rao S, Dinkar C, Vaishnav LK. et al. The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study. Integr Cancer Ther 2014; May 13 (03) 201-10
    CrossrefPubMedGoogle Scholar
  • 34 Ryan JL, Heckler CE, Ling M. et. al. Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. Radiat Res 2013; Jul 180 (01) 34-43
    CrossrefPubMedGoogle Scholar
  • 35 Schneider C, Gordon O. et al. Degradation of Curcumin. From mechanism to biological implications. J agric Food Chem 2015; Sep 9 63 (35) 7606-7614
    CrossrefPubMedGoogle Scholar
  • 36 Sharma V, Kumar L, Mohanty SK. et al. Sensitization of androgen refractory prostate cancer cells to anti-androgens through re-expression of epigenetically repressed androgen receptor – Synergistic action of quercetin and curcumin. Mol Cell Endocrinol 2016; Aug 15 431: 12-23
    CrossrefPubMedGoogle Scholar
  • 37 Shen L, Liu CC, An CY. et al. How does curcumin work with poor bioavailability? Clues from experimental and theoretical studies. Sci Rep 2016; Feb 18 6: 20872
    CrossrefPubMedGoogle Scholar
  • 38 Shindikar A, Singh A, Nobre M. et al. Curcumin and Resveratrol as Promising Natural Remedies with Nanomedicine Approach for the Effective Treatment of Triple Negative Breast Cancer. J Oncol. 2016 9750785: 1
    PubMedGoogle Scholar
  • 39 Solda C, Bardini R, Sperti C. et al. Phase II study of Gemcitabine and Curcumin (Meriva) as first line treatment for locally advanced or metastatic pancreatic cancer preliminary results. Annals of Oncology Vol 26, Issue suppl 6, 1, October 2015, p VI. Im Internet: http://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.e15696 Stand: 10.09.2017
    PubMedGoogle Scholar
  • 40 Turmeric or Curcumin: Plants vs. Pills. NutrionFacts.org.. https://youtu.be/4vcl24rnyb-o
    PubMedGoogle Scholar
  • 41 Vaz GR, Hädrich G, Bidone J. et al. Development of Nasal Lipid Nanocarriers Containing Curcumin for Brain Targeting. J Alzheimer Dis. 2017 Jul 17 (e publish)
    PubMedGoogle Scholar
  • 42 Wang K, Zhang C, Bao J. et al. Synergistic chemoprevention effects of curcumin and berberine on human breast cancer cells through induction of apoptosis and autophagic cell death. Sci Rep 2016; Jun 6 6: 26064
    CrossrefPubMedGoogle Scholar